Rachel specialises in corporate and securities law with particular expertise in equity capital markets and mergers and acquisitions.
Rachel has acted on many of New Zealand's most significant recent IPOs and NZX listings and other equity capital markets transactions. She has a reputation for ensuring these complex and involved processes run smoothly.
Rachel is recognised as a Rising Star in capital markets by the independent legal directories Asialaw and IFLR1000.
Rachel has advised:
- New Zealand King Salmon and Direct Capital on the proposed IPO and NZX Main Board and ASX listing of New Zealand King Salmon
- NZME on its demerger from APN News & Media, its subsequent listing on the NZX Main Board and ASX, and the proposed merger with Fairfax New Zealand
- First NZ Capital and Credit Suisse on SKYCITY's fully underwritten $263m accelerated renounceable entitlement offer
- Partners Life on Blackstone Group’s $200m investment into the insurer
- First NZ Capital as sole lead manager of AFT Pharmaceuticals’ $40m IPO and NZX Main Board listing
- Heartland on its amalgamation with Heartland Bank, and proposed $100m capital return by way of Court approved scheme of arrangement
- Deutsche Craigs on the $82m block trade of Chevron’s 11.3% stake, and on the $80m block trade with BP of an 11.1% stake, in The New Zealand Refining Company
- Snakk Media on its migration from the existing NZX Alternative Market to NZX’s new NXT market, one of the first companies to list on NXT
- EROAD on all aspects of its $46m IPO and NZX Main Board listing
- Scales Corporation and Direct Capital on the $149m IPO and NZX listing of Scales Corporation and on the subsequent sale of Direct Capital’s retained stake to China Resources Ng Fung
- Deutsche Craigs and First NZ Capital as joint lead managers of Orion Health’s IPO and NZX Main Board and ASX listing, and
- on two of the New Zealand Government’s Mixed Ownership Model programme transactions: the Treasury on the $736m IPO and NZX and ASX listing of Genesis Energy, and Mighty River Power (now Mercury) on its $1.7b IPO and NZX and ASX listing.